Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Hold period

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Oct 24, 2023 9:04am

191 Views

Post# 35697863

RE:Hold period

Makes sense to me, DJDawg. It'll be a miracle at this point if they get BTD any earlier than mid Q1. So this raise has to sustain them for 3-4 months at least. The stock will be in a rut till them because of the added bloat. Er, I mean float.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments